CCL2 and neoplasm: The results mirrored those observed in global Ccl2−/− mice, hematopoietic loss of CCL2 significantly reduced tumor burden and decreased extravascular recMac accumulation compared to WT chimeras (Fig. 4d–e; Supplementary Fig. 5).